Skip header and navigation

15 records – page 1 of 1.

Review of the Personal Information Protection and Electronic Documents Act (PIPEDA) : CMA's Presentation to the House of Commons Standing Committee on Access to Information, Privacy and Ethics - December 13, 2006

https://policybase.cma.ca/en/permalink/policy8668
Date
2006-Dec-13
Topics
Health care and patient safety
Health information and e-health
Ethics and medical professionalism
  1 document  

Recommendations pertaining to children's mental health

https://policybase.cma.ca/en/permalink/policy8507
Date
2006-Aug-23
Topics
Health systems, system funding and performance
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC06-15
The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
2006-Aug-23
Topics
Health systems, system funding and performance
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC06-15
The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
Less detail

Insurance fund of last resort

https://policybase.cma.ca/en/permalink/policy8520
Date
2006-Aug-23
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC06-16
The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
2006-Aug-23
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC06-16
The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
Less detail

Sale of clove, herbal and vitamin cigarettes

https://policybase.cma.ca/en/permalink/policy8547
Date
2006-Aug-23
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC06-77
The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
2006-Aug-23
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC06-77
The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
Less detail

Medical schools placing trainees

https://policybase.cma.ca/en/permalink/policy8550
Date
2006-Aug-23
Topics
Health human resources
Ethics and medical professionalism
Resolution
GC06-81
The Canadian Medical Association urges medical schools placing trainees in overlapping geographic areas to coordinate these placements cooperatively to ensure appropriate learning opportunities for trainees.
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
2006-Aug-23
Topics
Health human resources
Ethics and medical professionalism
Resolution
GC06-81
The Canadian Medical Association urges medical schools placing trainees in overlapping geographic areas to coordinate these placements cooperatively to ensure appropriate learning opportunities for trainees.
Less detail

Pharmacists who are given independent prescribing authority

https://policybase.cma.ca/en/permalink/policy8557
Date
2006-Aug-23
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
Resolution
GC06-67
The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
2006-Aug-23
Topics
Population health/ health equity/ public health
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
Resolution
GC06-67
The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
Less detail

Embryonic stem cell research

https://policybase.cma.ca/en/permalink/policy1619
Date
2003-Dec-06
Topics
Ethics and medical professionalism
Resolution
BD04-04-62
The Canadian Medical Association remains neutral on the issue of embryonic stem cell research.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2003-Dec-06
Topics
Ethics and medical professionalism
Resolution
BD04-04-62
The Canadian Medical Association remains neutral on the issue of embryonic stem cell research.
Less detail

The Right Drugs, at the Right Times, for the Right Prices: Toward a Prescription Drug Policy for Canada : CMA Presentation to House of Commons Standing Committee on Health

https://policybase.cma.ca/en/permalink/policy1955
Date
2003-Nov-06
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
  2 documents  

World Medical Association annual meeting

https://policybase.cma.ca/en/permalink/policy1612
Date
2003-Oct-04
Topics
Ethics and medical professionalism
Resolution
BD04-02-19
The Canadian Medical Association will continue its support for and participation in the work of the World Medical Association.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2003-Oct-04
Topics
Ethics and medical professionalism
Resolution
BD04-02-19
The Canadian Medical Association will continue its support for and participation in the work of the World Medical Association.
Less detail

Principles for providing information about prescription drugs to consumers

https://policybase.cma.ca/en/permalink/policy189
Date
2003-Mar-01
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Quality End-of-Life Care report

https://policybase.cma.ca/en/permalink/policy388
Date
2000-Aug-16
Topics
Ethics and medical professionalism
Resolution
GC00-19
That the Canadian Medical Association advise the Federal Minister of Health that it supports the recommendations of the Senate Standing Committee of the Senate "Quality End-of-Life Care" of June 2000, as appended to the Reports to General Council, and urge the government to work with provincial and territorial governments towards rapid implementation of the recommendations.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Ethics and medical professionalism
Resolution
GC00-19
That the Canadian Medical Association advise the Federal Minister of Health that it supports the recommendations of the Senate Standing Committee of the Senate "Quality End-of-Life Care" of June 2000, as appended to the Reports to General Council, and urge the government to work with provincial and territorial governments towards rapid implementation of the recommendations.
Less detail

Allocation of health care resources

https://policybase.cma.ca/en/permalink/policy389
Date
2000-Aug-16
Topics
Health systems, system funding and performance
Ethics and medical professionalism
Resolution
GC00-186
That the Canadian Medical Association work with its divisions and affiliates to determine and proclaim the values that should influence health care priority setting and allocation of health care resources in Canada.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Health systems, system funding and performance
Ethics and medical professionalism
Resolution
GC00-186
That the Canadian Medical Association work with its divisions and affiliates to determine and proclaim the values that should influence health care priority setting and allocation of health care resources in Canada.
Less detail

Essential drugs for the exclusive use of developing countries

https://policybase.cma.ca/en/permalink/policy415
Date
2000-Aug-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC00-221
The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC00-221
The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
Less detail

The future of medicine

https://policybase.cma.ca/en/permalink/policy209
Date
2000-Aug-12
Topics
Health systems, system funding and performance
Ethics and medical professionalism
  1 document  

Psycho-active substances and the operation of motor vehicles and industrial equipment

https://policybase.cma.ca/en/permalink/policy781
Date
1973-Jun-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC73-50
That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1973-Jun-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC73-50
That the membership of the Canadian Medical Association clearly inform its patients, and the general public at large, of the hazards associated with the operation of motor vehicles, industrial equipment, etc., while under the influence of psycho-active substances, especially alcohol and antihistamines, and particularly the combination of such substances.
Less detail

15 records – page 1 of 1.